Discover 1,068 paid clinical trials in Ogden, Utah. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,068
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Location: Salt Lake City UT, Houston TX, Jackson TN, Columbus GA,
Sponsor: Energenesis Biomedical Co., Ltd.
Sex: All
Age: 18+
Code: NCT05930210
Phase3, Recruiting
A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
for
Acute Treatment of Migraine
Location: Salt Lake City UT, Omaha NE, Tulsa OK, Dallas TX,
Sponsor: Pfizer
Sex: All
Age: 6 - 11
Code: NCT06995729
Phase1, Recruiting
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
for
Alzheimer Disease
Location: Salt Lake City UT, Las Vegas NV, Spokane WA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 55 - 70+
Code: NCT07011732
Phase3, Recruiting
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
for
Pediatric Migraine
Location: Salt Lake City UT, Aurora CO, Missoula MT,
Sponsor: Pfizer
Sex: All
Age: 6 - 17
Code: NCT04649242
Phase3, Recruiting
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
for
Acute Treatment of Migraine
Location: Salt Lake City UT, Aurora CO, Missoula MT,
Sponsor: Pfizer
Sex: All
Age: 6 - 17
Code: NCT04743141
Phase3, Recruiting
A Phase 1 Study of ARC-001 in Participants Undergoing Third Molar Extraction
for
Acute Post Operative Pain, Third Molar Extraction Surgery
Location: Salt Lake City UT
Sponsor: Arcato Laboratories, Inc.
Sex: All
Age: 18 - 55
Code: NCT06864884
Early_phase1, Recruiting
nCap Pain Relief Patch vs. Placebo
for
Osteoarthritis, Knee
Location: Salt Lake City UT
Sponsor: nCap Medical
Sex: All
Age: 40 - 70+
Code: NCT04753567
Recruiting
A Study to Evaluate Ibuprofen (IBU) 62.5 mg and Acetaminophen (APAP) 125 mg/5 ml in an Oral Liquid Suspension Fixed-Dose Combination Product in Children Aged 6 to 11 Years
for
Pain
Location: Salt Lake City UT
Sponsor: HALEON
Sex: All
Age: 6 - 11
Code: NCT07632274
Phase1, Recruiting
Sciatic Nerve Block With ALX006 in Subjects Undergoing Bunionectomy
for
Hallux Valgus, Bunionectomy
Location: Millcreek UT
Sponsor: Rebel Medicine Inc
Sex: All
Age: 18+
Code: NCT07574385
Phase2, Recruiting
iSTEP-N 101b: Pharmacokinetics and Safety Study of Low- and High-Dose Naltrexone Implants vs Monthly Vivitrol in Healthy Volunteers
for
Opioid Use Disorder
Location: Millcreek UT
Sponsor: Akyso Therapeutics, LLC
Sex: All
Age: 18 - 65
Code: NCT07064564
Phase1, Recruiting
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
for
Chronic Kidney Disease and Hypertension
Location: South Salt Lake UT, Arvada CO, Surprise AZ, Concord CA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06742723
Phase3, Recruiting
A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)
for
Metastatic Castration Resistant Prostate Cancer
Location: Murray UT, Fort Worth TX, Dallas TX, Houston TX,
Sponsor: ORIC Pharmaceuticals
Sex: Male
Age: 18+
Code: NCT07723248
Phase3, Recruiting
Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
for
Type 2 Diabetes Mellitus, T2DM
Location: Salt Lake City UT, Las Vegas NV, Mesa AZ, Fremont NE,
Sponsor: Hanmi Pharmaceutical Company Limited
Sex: All
Age: 18 - 70+
Code: NCT07527650
Phase2, Recruiting
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
for
Uterine Fibroids, Endometriosis
Location: Salt Lake City UT, Pleasant Grove UT, Idaho Falls ID,
Sponsor: Sumitomo Pharma Switzerland GmbH
Sex: Female
Age: 18 - 50
Code: NCT05862272
Phase3, Recruiting
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction